Dexcom (DXCM)

Sales/Maturities of Investments

$525.80M

Quarterly · Period ending: · USD

DXCM logo

DXCM Sales/Maturities of Investments

Latest reported$525.80M
DXCM Quarterly Sales/Maturities of Investments ($34.00M → $525.80M)
High-resolution chart · PNG

DXCM sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
525,800,000
468,200,000
409,600,000
466,200,000
638,700,000
650,200,000
405,200,000
630,600,000
666,800,000
1,121,800,000
719,000,000
671,400,000
859,400,000
697,600,000
740,000,000
602,200,000
543,800,000
241,800,000
501,000,000
537,000,000
838,300,000
790,000,000
952,000,000
449,000,000
319,500,000
530,000,000
423,400,000
259,200,000
291,300,000
222,500,000
161,100,000
155,600,000
42,500,000
32,900,000
46,400,000
27,400,000
10,700,000
8,900,000
9,500,000
7,500,000
10,600,000
11,100,000
8,700,000
9,600,000
4,500,000
4,700,000
3,400,000
3,800,000
3,400,000
2,600,000
6,700,000
7,400,000
12,100,000
18,900,000
18,075,000
20,387,000
25,269,000
40,569,000
24,710,000
19,518,000
7,500,000
12,558,000
11,650,000
13,453,000
12,386,000
17,202,000
18,373,000
18,200,000
10,283,000
7,000,000
10,501,000
12,099,000
8,992,000
32,210,000
31,540,000
8,405,000
13,495,000
18,503,000
11,626,621
14,569,000
6,000,000
6,330,000
9,000,000
0
0
34,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.